Jennifer Kuntz to United States
This is a "connection" page, showing publications Jennifer Kuntz has written about United States.
Connection Strength
0.202
-
Protection From COVID-19 Vaccination and Prior SARS-CoV-2 Infection Among Children Aged 6 Months-4 Years, United States, September 2022-April 2023. J Pediatric Infect Dis Soc. 2025 Jan 20; 14(1).
Score: 0.033
-
CASCADIA: a prospective community-based study protocol for assessing SARS-CoV-2 vaccine effectiveness in children and adults using a remote nasal swab collection and web-based survey design. BMJ Open. 2023 Jul 14; 13(7):e071446.
Score: 0.030
-
Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers. JAMA. 2022 10 18; 328(15):1523-1533.
Score: 0.028
-
Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients. JAMA. 2022 08 16; 328(7):637-651.
Score: 0.028
-
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-March 2021. MMWR Morb Mortal Wkly Rep. 2021 Apr 02; 70(13):495-500.
Score: 0.026
-
Incidence of Clostridioides difficile infections among young and middle-aged adults: Veterans Health Administration. Infect Control Hosp Epidemiol. 2019 09; 40(9):997-1005.
Score: 0.023
-
Clostridium difficile Infection Among Veterans Health Administration Patients. Infect Control Hosp Epidemiol. 2015 Sep; 36(9):1038-45.
Score: 0.017
-
Identification of Stevens-Johnson syndrome and toxic epidermal necrolysis in electronic health record databases. Pharmacoepidemiol Drug Saf. 2015 Jul; 24(7):684-92.
Score: 0.017